| |
Corneaa
|
TGb
|
|---|
|
Gene
|
3d
|
10d
|
30d
|
3d
|
10d
|
30d
|
|---|
|
CCR1
|
11 (9.2–12)
|
18 (13–23)
|
20 (10–26)
|
5 (2.2–7.1)
|
15 (9.0–19)
|
4 (1.7–7.0)
|
|
CCR2
|
14 (9.2–19)
|
22 (11–32)
|
14 (8.1–24)
|
3 (1.5–4.2)
|
15 (11–19)
|
3 (1.3–4.4)
|
|
CCR3
|
2 (1.0–5.0)
|
3 (2.0–5.0)
|
3 (2.5–3.3)
|
2 (0.5–5.0)
|
8 (2.2–20)
|
3 (1.8–4.7)
|
|
CCR5
|
12 (12.3–12.5)
|
11 (8.0–14)
|
20 (8.9–36)
|
9 (4.8–11)
|
57 (22–110)
|
9 (7.0–10)
|
|
CCR6
|
3 (2.4–3.0)
|
2 (1.0–2.5)
|
5 (1.5–8.5)
|
3 (0.3–11)
|
3 (1.0–5.0)
|
14 (1.0–40)
|
|
CCR7
|
24 (8.0–40)
|
5 (3.0–6.5)
|
17 (13–21)
|
13 (9.0–17)
|
19 (17–20)
|
7 (2.0–11)
|
|
CXCR3
|
10 (5.0–18)
|
15 (8.0–23)
|
5 (2.8–6.5)
|
2 (1.0–4.0)
|
104 (54–160)
|
36 (14–59)
|
|
CXCR4
|
11 (4.8–14)
|
3 (1.7–4.0)
|
45 (33–74)
|
0.6 (0.4–0.9)
|
4 (2.9–6.2)
|
3 (2.3–3.7)
|
|
MIP-1α
|
69 (33–106)
|
394 (263–1700)
|
34 (16–53)
|
232 (80–471)
|
126 (80–168)
|
25 (13–45)
|
|
MIP-1β
|
53 (39–67)
|
285 (261–310)
|
16 (11–21)
|
282 (10–595)
|
230 (202–245)
|
31 (24–37)
|
|
RANTES
|
55 (36–73)
|
43 (38–48)
|
16 (12–18)
|
64 (61–66)
|
304 (302–306)
|
31 (12–50)
|
|
MCP-1
|
54 (52–55)
|
64 (55–74)
|
12 (7.5–20)
|
153 (113–194)
|
22 (16–27)
|
3 (1.6–4.2)
|
|
Eotaxin-1
|
3 (1.9–3.5)
|
1 (0.6–1.3)
|
3 (1.0–5.4)
|
5 (3.3–9.1)
|
2 (1.2–2.8)
|
1.5 (0.7–2.3)
|
|
IFNγ
|
Inf.c
|
Inf.
|
Inf.
|
Inf.
|
Inf.
|
Inf.
|
|
TNF-α
|
3 (2.9–3.0)
|
3 (2.6–3.8)
|
7 (3.9–12)
|
Inf.
|
Inf.
|
Inf.
|
- a Induction ratios were calculated as relative expression in HSV-infected/relative expression in mock-infected cornea. Each value is the average of induction ratios (2 or 3 separate measurements per cDNA sample) from two independent experiments. Ranges of individual ratios are in parentheses.
- b Induction ratios were calculated for HSV- vs. mock-infected TG as in footnote a. Each value is the average of induction ratios (2 or 3 separate measurements per cDNA sample) from three independent experiments, with ranges in parentheses.
- c Inf., infinite due to relative expression = 0 in all or most mock-infected samples.
